Tampa, FL, June 21 2023 – Marketdata LLC, a leading market research firm tracking the weight loss market since 1989, has just released a new report: “The U.S. Medical Weight Loss Market”. This 150-page report is the most comprehensive analysis of the medical weight loss market and its competitors ever published – covering programs by independent MDs, hospitals, clinics, franchises, the bariatric surgery market, plans by bariatricians, plans by VLCD vendors, and the prescription diet drugs market.
“The tide has turned to a greater focus on medical weight loss programs, many of which are now using the new obesity drugs. The big story of 2022 has been the soaring demand for new drugs such as Wegovy, Ozempic and Saxenda, with more new drugs coming soon.”, according to Research Director, John LaRosa.
- The value of the U.S. medical weight loss market is estimated to have grown 17% during 2022, to $8.8 billion, recovering ground lost to the pandemic and fueled by a near doubling of obesity drug sales. Another 10% gain is forecast for 2023.
- Medical weight loss programs represented 11.7% of the total $75.5 billion U.S. weight loss market in 2022, and this share is forecast to rise to 13.4% by 2027.
- Medical weight loss franchises are estimated to generate $150 million in system-wide sales annually.
- The market may be entering a new era focused on medical approaches, as a new generation of prescription obesity drugs from Novo Nordisk, Eli Lilly and others hit the market. Even Weight Watchers now provides a medical plan. The prescription obesity drugs market nearly doubled to $1.56 billion in 2022, due to the high demand for new semaglutide drugs.
- The weight loss surgery market is valued at $5.7 billion, slated to grow to $8.5 billion by 2027. This will involve 340,000 yearly procedures.
- Medical weight loss programs offered by bariatricians (MDs who are board-certified to treat obesity) is a $368 million market. An estimated 63,000 physicians nationwide have some form of weight loss program.
- The number of medical weight loss centers or program sites is estimated to have fallen 10% from 2019 to 2023, to about 3,548. Most of the medical franchises operate less sites today than before the pandemic, but this may reverse course soon.
- Hospitals have had a mixed record with weight loss programs (excluding surgery). Only 28% of the nation’s 4,000 community hospitals provide some form of weight loss program – 1,150 hospitals.
- There are 108 million Americans that are obese (a BMI of 30+). This is the prime universe of candidates for a medical weight loss program.
“Like commercial weight loss centers, medical weight loss programs have pivoted to a mix of virtual client meetings and in-person care.”, according to Research Director, John LaRosa.
About The Report
“The U.S. Medical Weight Loss Market”, April 2023, is a 150-page independent analysis of all segments of the medical weight loss market. It contains in-depth competitor profiles and 40 tables and charts. Coverage of: the prescription obesity drugs market, medical weight loss programs by: hospitals, clinics and MD offices, bariatrician programs, and weight loss surgery. Extensive coverage of the effects of the pandemic and effect on operations and revenues. $ market size from 1997-2022. 2023 & 2027 Outlook and Forecasts. The report’s price is $995. The report may be purchased and a Table of Contents can be found at: www.marketdataenterprises.com. Contact: Marketdata LLC, 7210 Wareham Drive, Tampa, FL 33647, (813-971-8080. John LaRosa is available for interviews.
Marketdata LLC is a 44-year old, independent market research firm with a specialty tracking the weight loss market since 1989. It publishes a wide variety of reports about service and healthcare sectors, and does consulting, custom research projects, and teleconference calls. Marketdata also operates a free website, www.DietBusinessWatch.com, updated daily with the latest weight loss market and competitor news, analyses and a blog by John LaRosa.
Marketdata Enterprises, Inc., Tampa, FL